Plain-English translation of NCT07381296 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is trying to find a simple, inexpensive way to predict when people with rheumatoid arthritis might experience a disease flare—a sudden worsening of symptoms. Researchers will collect blood samples and track disease activity every three months over 17 months to see if certain patterns in basic blood work can warn patients and doctors about an upcoming flare before it happens.
Even when rheumatoid arthritis is well-controlled, about 30% of patients experience unpredictable flares that cause pain, disability, and joint damage. Right now, doctors don't have a reliable way to predict these flares, so this study aims to develop an affordable blood test that could catch warning signs early.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic every three months for 17 months. At each visit, your doctor will assess your disease activity using a standard scoring system, and you'll have a blood test drawn. Researchers will track whether you experience any disease flares during this time and use your blood test results to look for patterns that might predict future flares.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt
Enrollment target
~200 participants
Started
February 2026
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Esraa Mohamed Mahmoud Sayed
Sohag University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.